MedTrace Logo

CASITA Intervention for Children at Risk of Delay in Carabayllo, Peru

NCT03010306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2017-01-16

No results posted yet for this study

Summary

Building on an intervention for early child development from the SPARK Center in Boston, Socios En Salud (SES) pilot tested "CASITA" a community-based package to screen and treat young children (ages 1-3 years of age) diagnosed with neurodevelopment risk and delay in Carabayllo, Lima, Peru. Ministry of Health CHWs identified children with developmental delays within the clinics and community and delivered a structured early intervention that included parent coaching and social support. In order to test the hypothesis that CASITA improves early child development, caregiver, and home environment, dyads received either nutrition supplements alone, nutrition + "CASITA" early child development sessions individually, or CASITA in a group of 10 dyads.

Conditions

  • Child Developmental Delay
  • Child Development
  • Community Health Workers
  • Low Income Population

Interventions

OTHER

CASITA

Sponsors & Collaborators

  • Grand Challenges Canada

    collaborator OTHER

  • Harvard University

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • Boston Medical Center

    collaborator OTHER

  • Partners in Health

    collaborator OTHER

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Leonid Lecca, MD · Socios En Salud, Peru

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010306 on ClinicalTrials.gov